Virtual Health Insurance Navigation for Childhood Cancer Survivors
(HINTII Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests two methods to help childhood cancer survivors better understand and manage their health insurance. The goal is to determine whether a live, virtual program (HINT-S) or a prerecorded version (HINT-A) of the Health Insurance Navigation Tools Program more effectively reduces worries about medical costs and improves healthcare access. The trial will also compare these methods to standard care, which includes a helpful booklet. Childhood cancer survivors currently in the Long-Term Follow-Up (LTFU) program, with U.S. health insurance and access to the CCSS patient portal, might be suitable candidates. As an unphased trial, this study offers a unique opportunity to contribute to improving healthcare navigation for childhood cancer survivors.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this virtual health insurance navigation program is safe?
Research shows that the Health Insurance Navigation Tools (HINT) program is practical and popular among childhood cancer survivors. Studies have found that participants accept this virtual program, with no reports of negative effects. It helps users understand and manage their health insurance better, reducing worries and unmet healthcare needs. As it is not a medical treatment, there are no physical safety concerns like those in drug trials. The program aims to improve long-term outcomes by increasing understanding of health insurance.12345
Why are researchers excited about this trial?
Researchers are excited about the Virtual Health Insurance Navigation Tools (HINT) program because it aims to simplify health insurance navigation for childhood cancer survivors, a group that can face complex health insurance challenges. Unlike current options that might not offer tailored support, the HINT program provides personalized guidance through two styles: a live, interactive version and a recorded, on-demand version. These interventions are designed to empower survivors with knowledge and confidence in managing their health insurance, potentially reducing stress and improving access to necessary care.
What evidence suggests that this trial's interventions could be effective for improving health insurance literacy in childhood cancer survivors?
Research has shown that tools designed to help understand health insurance benefit childhood cancer survivors. A small study found that these tools improve comprehension and use of health insurance, reducing worry and unmet health care needs. Childhood cancer survivors find the tools easy to use and favorable. In this trial, participants will use one of two versions of the tool: a live online version (HINT-S) or a recorded version (HINT-A), to determine which is more effective.23456
Who Is on the Research Team?
Elyse R Park, Ph.D., MPH
Principal Investigator
MGH
Are You a Good Fit for This Trial?
This trial is for adults over 18 who survived childhood cancer. They must be able to consent, have US health insurance, internet access via a smart device, and be part of the LTFU cohort with access to the CCSS patient portal. Those from the pilot trial can't join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive either the HINT-S synchronous or HINT-A asynchronous navigation intervention, or enhanced usual care
Follow-up
Participants are monitored for changes in health insurance literacy, financial hardship, healthcare utilization, and out-of-pocket costs
What Are the Treatments Tested in This Trial?
Interventions
- Health Insurance Navigation Tools Program
Trial Overview
The study tests two programs: HINT-S (live sessions) and HINT-A (prerecorded), against enhanced usual care. It aims to see if these programs improve health insurance literacy, reduce worry about costs, meet healthcare needs better, and improve long-term outcomes.
How Is the Trial Designed?
3
Treatment groups
Experimental Treatment
Active Control
a virtual, synchronous version of the 5 HINT-S navigator sessions + HINT booklet
a prerecorded, asynchronous version of the 5 HINT-S navigator sessions + HINT booklet
HINT Booklet
Find a Clinic Near You
Who Is Running the Clinical Trial?
Massachusetts General Hospital
Lead Sponsor
Published Research Related to This Trial
Citations
A Pilot Trial Within the Childhood Cancer Survivor Study - PMC
We report on the intervention development and randomized pilot trial results of a health insurance navigation tools (HINT) program. METHODS.
Health Insurance Navigation Tools Intervention: A Pilot ...
Childhood cancer survivors are at increased risk for underinsurance and health insurance–related financial burden.
NCT05527392 | Virtual Health Insurance Navigation Pilot ...
The present study seeks to evaluate a health insurance navigation program with childhood cancer survivors recruited from the Long-Term Follow-Up (LTFU) Cohort.
Assessing the effect of virtual navigation interventions to ...
This trial will elucidate the potential effectiveness and implementation of health insurance navigation programs that may benefit many cancer survivors.
5.
massgeneral.org
massgeneral.org/news/research-spotlight/enhancing-health-insurance-literacy-in-childhood-cancer-survivorsEnhancing Health Insurance Literacy in Childhood Cancer ...
Results support the feasibility and acceptability of a virtual health insurance navigation program targeted for childhood survivors.
A Pilot Trial Within the Childhood Cancer Survivor Study
Results support the feasibility and acceptability of a virtual health insurance navigation program targeted for childhood survivors to ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.